STAB

Statera Biopharma, Inc. Common Stock

Delisted

STAB was delisted on the 11th of January, 2023.

12 hedge funds and large institutions have $727K invested in Statera Biopharma, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$493K +$10.2K +6,100 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$176K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$27K
BlackRock
4
BlackRock
New York
$23K -$1.51K -896 -6%
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$6K
Carson Wealth (CWM LLC)
6
Carson Wealth (CWM LLC)
Nebraska
$2K +$2K +438 New
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
-$15K -15,268 Closed
UBS Group
8
UBS Group
Switzerland
-$6K -5,981 Closed